Graig Suvannavejh analyst MIZUHO

Currently out of the existing stock ratings of Graig Suvannavejh, 115 are a BUY (68.05%), 48 are a HOLD (28.4%), 6 are a SELL (3.55%).

Graig Suvannavejh

Work Performance Price Targets & Ratings Chart

Analyst Graig Suvannavejh works at MIZUHO with a stock forecast success ratio of 57.17% fulfilled within 90.97 days on average.

Graig Suvannavejh’s has documented 351 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on IMTX, Immatics NV at 16-May-2024.

Wall Street Analyst Graig Suvannavejh

Analyst best performing recommendations are on ADVM (ADVERUM BIOTECHNOLOGIES).
The best stock recommendation documented was for ADVM (ADVERUM BIOTECHNOLOGIES) at 4/28/2020. The price target of $17 was fulfilled within 7 days with a profit of $4.84 (39.8%) receiving and performance score of 56.86.

Average potential price target upside

ALEC Alector ARQT Arcutis Biotherapeutics  BTAI BioXcel Therapeutics CERE Cerevel Therapeutics Holdings CYTK Cytokinetics FLXN Flexion Therapeutics HALO Halozyme Therapeutics HRMY Harmony Biosciences Holdings INSM Insmed ITCI Intracellular Th JAZZ Jazz Pharmaceuticals PLC KOD Kodiak Sciences ORTX Orchard Therapeutics PLC TGTX TG Therapeutics ATHA Athira Pharma  GMTX Gemini Therapeutics MOR MorphoSys AG ADR RYTM Rhythm Pharmaceuticals XEC Cimarex Energy Co AXSM Axsome Therapeutics RAIN Rain Therapeutics ADVM Adverum Biotechnologies AMLX Amylyx Pharmaceuticals HZNP Horizon Pharma PLC IMCR Immunocore Holdings Ltd IMTX Immatics NV MNTA Momenta Pharmaceuticals PTLA Portola Pharmaceuticals TCDA Tricida AUTL Autolus Therapeutics Ltd EYPT Eyepoint Pharmaceuticals KRTX Karuna Therapeutics TERN Terns Pharmaceuticals VIGL Vigil Neuroscience APLS Apellis Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

35

$29.56 (543.38%)

41

10 days ago

0/5 (0%)

$29.8 (573.08%)

Buy

15

$9.56 (175.74%)

8

5 months 5 days ago

1/4 (25%)

$7 (87.50%)

128

Buy

9

$3.56 (65.44%)

10

6 months 2 days ago

1/5 (20%)

$4.69 (108.82%)

24

Sell

4

$-1.44 (-26.47%)

9

7 months 24 days ago

2/2 (100%)

$-2.98 (-42.69%)

36

Hold

10

$4.56 (83.82%)

10

9 months 12 days ago

1/5 (20%)

$2.64 (35.87%)

332

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Graig Suvannavejh is most bullish on?

Potential upside of $34.71 has been obtained for IMCR (IMMUNOCORE HOLDINGS LTD)

Which stock is Graig Suvannavejh is most reserved on?

Potential downside of -$4.71 has been obtained for HALO (HALOZYME THERAPEUTICS)

What Year was the first public recommendation made by Graig Suvannavejh?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?